Change lifestyle before giving children weight loss medication, WHO says
The World Health Organization (WHO) has urged health authorities to first seek lifestyle interventions to treat obesity in children and…
08 Oct 2026
FDA approves Pfizer’s Tukysa regimen for metastatic breast cancer
The US Food and Drug Administration (FDA) has approved Pfizer’s Tukysa (tucatinib) along with pertuzumab and trastuzumab as a maintenance therapy for breast cancer. This regimen is indicated for adults…
08 Oct 2026
10x Genomics and Fred Hutch partner on cancer technologies
10x Genomics has entered into a multi-project research agreement with Fred Hutchinson Cancer Center (Fred Hutch) for advancing single cell as well as spatial platforms in solid tumours and blood…
07 Oct 2026
CAR-T specialist Caribou culls pipeline and seeks exit deal
Caribou Biosciences, a biotech developing off-the-shelf cell therapies for blood cancers, said it will discontinue its pipeline and lay off employees – a move that reflects shifting investor appetite towards…
07 Oct 2026
KymaThera pulls in $80m to bring breast cancer drug to clinic
San Diego-based biotech KymaThera has banked $80m in a Series B funding round to bring a breast cancer drug to clinic that it claims may overcome the challenges linked to…
07 Oct 2026
Rocket receives $150m credit facility to advance cardiovascular portfolio
Rocket Pharmaceuticals has entered into a credit facility agreement of up to $150m with Hercules Capital to support the ongoing development of its cardiovascular portfolio. The financing arrangement extends the…
07 Oct 2026
Gilead Sciences signs five-year DevOps agreement with Cognizant
Gilead Sciences has signed a five-year agreement extension with Cognizant to advance its DevOps environment and support the deployment of agentic AI tools across designated technology initiatives. The renewed arrangement…